Corcept Therapeutics Incorporated (CORT)

Financial leverage ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	621,517	583,430	423,756	571,731	412,312
Total stockholders’ equity	US$ in thousands	506,705	501,842	375,806	523,338	371,182
Financial leverage ratio		1.23	1.16	1.13	1.09	1.11

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $621,517K ÷ $506,705K
= 1.23

Based on the data provided, Corcept Therapeutics Inc's financial leverage ratio has been gradually increasing over the past five years. The ratio stands at 1.23 as of December 31, 2023, up from 1.16 in the previous year and showing a consistent upward trend since 2019.

This indicates that the company is increasingly relying on debt to finance its operations and growth. A financial leverage ratio above 1 suggests that the company has more debt than equity in its capital structure. While some level of financial leverage can amplify returns for shareholders in good times, it also exposes the company to higher financial risk, especially in times of economic downturns or adverse market conditions.

Investors and stakeholders should closely monitor Corcept Therapeutics Inc's financial leverage ratio over time to assess the company's ability to meet its debt obligations and the overall risk associated with its capital structure.